News

Van Eyk sale 'won't change research product'

Wednesday 10th of April 2013

The 38% stake was sold for A$13.3 million to Merrick Capital, although PGC will retain a convertible note holding.

Van Eyk chief executive Mark Thomas said it would not make a difference to the operation of Van Eyk. “Our product and services offering will not change as a result of the sale, nor will our management or strategic direction. As a business, we continue to operate on the same...

Want to read the full article?
Click the button below to subscribe and will have unlimited access to full article and all other articles on the site.